Pictet Asset Management (UK)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$48.4M Sell
1,066,609
-7,956
-0.7% -$352K 0.05% 352
2021
Q1
$44.8M Sell
1,074,565
-641,482
-37% -$29.3M 0.05% 351
2020
Q4
$73.3M Sell
1,716,047
-757,890
-31% -$27.2M 0.1% 248
2020
Q3
$65M Sell
2,473,937
-476,752
-16% -$13.3M 0.1% 235
2020
Q2
$79.1M Buy
2,950,689
+1,166,221
+65% +$26.3M 0.14% 195
2020
Q1
$32.1M Sell
1,784,468
-1,084,458
-38% -$20.6M 0.07% 282
2019
Q4
$50.9M Sell
2,868,926
-148,380
-5% -$2.57M 0.09% 260
2019
Q3
$46.8M Sell
3,017,306
-694,756
-19% -$11.4M 0.1% 235
2019
Q2
$63.8M Sell
3,712,062
-189,509
-5% -$3.06M 0.14% 192
2019
Q1
$62.8M Buy
3,901,571
+185,763
+5% +$3.01M 0.14% 204
2018
Q4
$54.4K Buy
3,715,808
+347,674
+10% +$5.55M 0.14% 202
2018
Q3
$61.2M Buy
3,368,134
+727,372
+28% +$12.7M 0.13% 215
2018
Q2
$44.5M Buy
2,640,762
+172,434
+7% +$3.26M 0.11% 239
2018
Q1
$48.4M Buy
2,468,328
+14,826
+0.6% +$287K 0.12% 239
2017
Q4
$49.7M Buy
2,453,502
+565,076
+30% +$10.4M 0.13% 222
2017
Q3
$32.8M Buy
1,888,426
+339,801
+22% +$4.6M 0.09% 274
2017
Q2
$18.3M Buy
1,548,625
+91,199
+6% +$1.22M 0.06% 366
2017
Q1
$18.9M Buy
+1,457,426
New +$18.4M 0.06% 361
2016
Q4
Sell
-114,053
Closed -$1.38M 858
2016
Q3
$1.38M Hold
114,053
0.01% 764
2016
Q2
$1.15M Buy
114,053
+71,953
+171% +$710K ﹤0.01% 783
2016
Q1
$342K Sell
42,100
-261,700
-86% -$2.46M ﹤0.01% 807
2015
Q4
$5.26M Buy
303,800
+27,000
+10% +$430K 0.02% 545
2015
Q3
$3.72M Buy
276,800
+37,300
+16% +$749K 0.02% 618
2015
Q2
$5.59M Sell
239,500
-233,430
-49% -$4.1M 0.02% 564
2015
Q1
$7.03M Sell
472,930
-110,545
-19% -$1.59M 0.03% 508
2014
Q4
$5.63M Buy
583,475
+269,875
+86% +$2.4M 0.03% 545
2014
Q3
$2.85M Buy
313,600
+5,000
+2% +$47.6K 0.01% 677
2014
Q2
$3.05M Buy
308,600
+4,300
+1% +$36.5K 0.01% 666
2014
Q1
$3.87M Sell
304,300
-12,800
-4% -$190K 0.02% 604
2013
Q4
$4.75M Buy
317,100
+25,100
+9% +$323K 0.02% 519
2013
Q3
$3.22M Buy
292,000
+60,000
+26% +$500K 0.02% 630
2013
Q2
$1.84M Buy
+232,000
New +$1.48M 0.01% 731

Other funds holding HALO

Pictet Asset Management (UK)'s HALO Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Halozyme (HALO) stake by 0.74% in Q2 2021, selling an estimated $352K and leaving 1,066,609 shares worth $48.4M. The position accounts for 0.05% of the portfolio, ranked #352.

Pictet Asset Management (UK) first reported a position in HALO in Q2 2013 and has held it in 32 quarters since. The position peaked at $79.1M in Q2 2020. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

  • Pictet Asset Management (UK) held 1,066,609 shares of Halozyme worth $48.4M as of Q2 2021.
  • Pictet Asset Management (UK) sold 7,956 Halozyme shares in Q2 2021, an estimated $352K.
  • Halozyme made up 0.05% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #352 holding.
  • Pictet Asset Management (UK) first reported a position in Halozyme in Q2 2013 and has held it in 32 quarters since.
  • Pictet Asset Management (UK)'s Halozyme position peaked at $79.1M in Q2 2020.
  • 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.